p53 and K-ras Expression in Interstitial Lung Disease

Oh, In Jae; Kim, You Il; Kim, Kyu Sik; Yoo, Young Kwon; Kim, Soo Ok; Lee, Eun Woo; Lim, Sung Chul; Kim, Young Chul; Park, Kyung Ok; Park, Chang Soo

Abstract

BACKGROUND
Approximately 10-13% of patients with interstitial lung disease(ILD) die of lung cancer, and patients with ILD have been reported to have a 7 fold higher incidence of lung cancer compared to the normal population. Recently, overexpression of the p53 and p21 proteins were observed in the epithelial cells from pathologic specimens of ILD. Overexpression of these proteins may result from chronic or recurrent DNA damage by unknown causes of inflammation. However, these proteins may also contribute to oncogenesis if other genetic alterations such as K-ras are superimposed.
METHODS
Immunohistochemical stains for p53 and K-ras proteins were performed with pathologic specimens from 38 cases with ILD(M/F:27/11, mean agea:54±10 years) and from 10 control subjects.
RESULTS
The p53 protein was expressed in 21.1% (8/38 ILD cases) and K-ras protein expression was observed in 65.8% (25/38 ILD cases). However, neither p53 nor the K-ras protein staining was observed in the control subjects.
CONCLUSION
A significant proportion of cases with ILD expressed the p53 and K-ras proteins in their bronchial epithelial cells. These proteins may be potentially oncogenic with the addition of further genetic alterations. However, to clarify the significance of these findings, further studies looking for correlations with the incidence of lung cancer and other genetic changes are needed.